SunTrust Robinson Humphrey Initiates Coverage On Alexion Pharmaceuticals with Buy Rating, Announces $125 Price Target

SunTrust Robinson Humphrey initiates coverage on Alexion Pharmaceuticals (NASDAQ:ALXN) with a Buy rating and a $125 price target.

Benzinga · 11/12/2019 11:04

SunTrust Robinson Humphrey initiates coverage on Alexion Pharmaceuticals (NASDAQ:ALXN) with a Buy rating and a $125 price target.